NPS Pharmaceuticals, Inc. (NPSP) Posts Wider than Expected Q4 Loss
Tweet
Share
E-mailGet Alerts NPSP Hot Sheet
Price: $45.97 --0%
Financial Fact:
Research and development: 24.53M
Today's EPS Names:
CMCT, STEX, PWCM, More
Financial Fact:
Research and development: 24.53M
Today's EPS Names:
CMCT, STEX, PWCM, More
Join SI Premium – FREE
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) reported Q4 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $26.3 million versus the consensus estimate of $26.17 million.
For earnings history and earnings-related data on NPS Pharmaceuticals, Inc. (NPSP) click here.
For earnings history and earnings-related data on NPS Pharmaceuticals, Inc. (NPSP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
